High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

PurposeModern literature has demonstrated improvements in long-term biochemical outcomes with the use of prophylactic pelvic nodal irradiation followed by a brachytherapy boost in the management of high-risk prostate cancer. However, this comes at the cost of increased treatment-related toxicity. In...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jonathan W. Lischalk, Meredith Akerman, Michael C. Repka, Astrid Sanchez, Christopher Mendez, Vianca F. Santos, Todd Carpenter, David Wise, Anthony Corcoran, Herbert Lepor, Aaron Katz, Jonathan A. Haas
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-02-01
Edice:	Frontiers in Oncology
Témata:	prostate stereotactic body radiation therapy high-risk pelvic nodes boost
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1325200/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!